Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous SVF for Chronic Leg Ulcers
NCT02987101Unknown
- Sponsor
- University Hospital Odense
- Start
- Nov 2016
- Primary completion
- Jun 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Randomised, open-label trial in leg ulcer comparing Autologous SVF + Standard of care with Standard of care (2 arms). Primary endpoint: Change in wound size at 6 months. Status: unknown.
02
Drugs
autologous adipose stromal vascular fraction
03
Conditions
leg ulcer
Beyond the preview
Go deeper on NCT02987101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02987101.